title: IVIg in the treatment of patients with factor VIII inhibitors.
authors.affiliation: Centre des Hémophiles, Hôpital Cochin, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Sultan
authors.forename: U
authors.initials: U
authors.lastname: Nydegger
authors.forename: M D
authors.initials: MD
authors.lastname: Kazatchkine
authors.forename: F
authors.initials: F
authors.lastname: Rossi
authors.forename: M
authors.initials: M
authors.lastname: Algiman
authors.forename: G
authors.initials: G
authors.lastname: Dietrich
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology; D005260:Female; D006467:Hemophilia A / Q000097:blood / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D005169:Factor VIII